MedPath

BASIL-2: Bypass v Angioplasty in Severe Ischaemia of the Leg - 2

Not Applicable
Completed
Conditions
Severe ischaemia of the lower limb due to infrageniculate arterial disease
Circulatory System
Registration Number
ISRCTN27728689
Lead Sponsor
niversity of Birmingham (UK)
Brief Summary

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/26739146 protocol 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37116524/ (added 02/05/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
345
Inclusion Criteria

1. Have Severe Limb Ischaemia (SLI) due to infra-popliteal (IP), with or without femoro-popliteal (FP) disease
2. Be judged by the responsible clinicians (consultant vascular surgeon (VS), interventional radiologist (IR), diabetologists) working as part of a multi-disciplinary team (MDT) to require early infra-popliteal (IP), with or without femoro-popliteal (FP), revascularisation in addition to Best Medical Treatment (BMT), foot and wound care
3. Have Aorto-Iliac (AI) ?inflow? adequate to support Vein Bypass (VB) and Best Endovascular Treatment (BET) (if not, then patients can be randomised after a successful AI procedure which can be either surgical or endovascular)
4. Be judged suitable for both Vein Bypass and Best Endovascular Treatment following diagnostic imaging and a formal (documented) discussion by consultant vascular surgeon and interventional radiologist in a properly constituted multi-disciplinary team meeting

Exclusion Criteria

Patients will be excluded if they:
1. Have an anticipated life expectancy <6 months
2. Are unable to provide consent due to incapacity (as defined by Mental Capacity Act 2005 or Adults with Incapacity [Scotland] Act 2000)
3. Are a non-English speaker where translation facilities are insufficient to guarantee informed consent
4. Are judged unsuitable for either of the two revascularisation strategies by the responsible consultant VS and IR

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.